However, the expression level of PIGF in stage II HNSCC is lower than that in stage I. These results collectively underscore the significant upregulation of PIGF in HNSCC, its diagnostic potential, and its variable expression across different tumor stages, enhancing our understanding of its role in cancer progression. Here, PIGF is linked to head and neck squamous cell carcinoma.